Fatemeh Hajibabaee¹ and Hadis Ashrafizadeh²*

¹Assistant Professor, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
²PhD Candidate, Student Research Committee, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

*Corresponding Author: Hadis Ashrafizadeh, PhD Candidate, Student Research Committee, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Received: April 27, 2021; Published: May 29, 2021

Abstract

  Due to the rapid growth of the elderly population, one of the most important challenges in this field is the higher prevalence of age-related degenerative diseases. Alzheimer's disease (AD) is a common disorder with severe and progressive disability in these people, which is eventually referred to as a deadly disease. End-of-life care is care in a situation where the disease leads to death. The purpose of this care is to achieve a good and calm death for the patient, and consolation for the family, therefore, due to the increasing growth of the phenomenon of aging, the high prevalence of this incurable disease, the limitation of special beds, human resources, financial and equipment in medical centers, the provision of end-of-life care is of particular importance. This method of care is considered as one of the important priorities of the health system so that patients and their families can adapt to the disease process and increase their quality of life in the last days of their lives, reduce pain, and experience a quiet death. Therefore, the present study will have a brief overview of the importance of end-of-life care in patients with AD.

Keywords: Alzheimer's Disease; Patient; Dementia

References

1. Villemagne VL., et al. “Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study”. The Lancet Neurology4 (2013): 357-367.
2. Braak H., et al. “Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years”. Journal of Neuropathology and Experimental Neurology11 (2011): 960-969.
3. Gordon BA., et al. “Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study”. The Lancet Neurology3 (2018): 241-250.
4. Bateman RJ., et al. “Clinical and biomarker changes in dominantly inherited Alzheimer's disease”. New England Journal of Medicine 367 (2012): 795-804.
5. Association AP. “Diagnostic and statistical manual of mental disorders (DSM-5®)”. American Psychiatric Pub (2013).
6. McGill-Carter T. “Market analysis alzheimers disease 2020”. Market Analysis1 (2020): 1-4.
7. “Association As 2018 Alzheimer's disease facts and figures”. Alzheimer's and Dementia3 (2018): 367-429.
8. Batiste XG and Connor SR. “Building integrated palliative care programs and services”. Càtedra de Cures Palliatives (2017).
9. Melinda Ratini D MS. “Alzheimer’s Disease and Care at the End of Life”. WebMD Medical Reference in Collaboration with the Cecil G. Sheps Center at the University of North Carolina at Chapel Hill (2020).
10. Izumi S., et al. “Defining end-of-life care from perspectives of nursing ethics”. Nursing Ethics5 (2012): 608-618.
11. Health NIo. “National institutes of health state-of-the-science conference statement of improving end-of-life care” (2011).
12. Karlou C., et al. “Caring behaviours in cancer care in Greece. Comparison of patients', their caregivers' and nurses' perceptions”. European Journal of Oncology Nursing3 (2015): 244-250.
13. Beckstrand RL., et al. “Providing a “good death”: critical care nurses’ suggestions for improving end-of-life care”. American Journal of Critical Care1 (2006): 38-45.
14. Hunt KJ., et al. “End-of-life care and preferences for place of death among the oldest old: Results of a population-based survey using VOICES–Short Form”. Journal of Palliative Medicine2 (2014): 176-182.
15. Pal RY., et al. “Death among elderly patients in the emergency department: a needs assessment for end-of-life care”. Singapore Medical Journal3 (2017): 129.
16. Martinsson L., et al. “Quality of end-of-life care in patients with dementia compared to patients with cancer: A population-based register study”. PloS One7 (2018): e0201051-e.
17. Sampson EL., et al. “Differences in care received by patients with and without dementia who died during acute hospital admission: a retrospective case note study”. Age Ageing2 (2006): 187-189.
18. Mitchell SL., et al. “Hospice care for patients with dementia”. Journal of Pain and Symptom Management1 (2007): 7-16.
19. Ahronheim JC., et al. “Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer”. Archives of Internal Medicine18 (1996): 2094-2100.
20. McCarthy M., et al. “The experience of dying with dementia: a retrospective study”. International Journal of Geriatric Psychiatry 3 (1997): 404-409.
21. Society A. “End of life care and physical needs” (2020).
22. Trinh E., et al. “End-of-Life Care of Persons With Alzheimer Disease: An Update for Clinicians”. American Journal of Hospice and Palliative Medicine®4 (2020): 314-317.
23. Weil AR. “Advanced illness and end-of-life care” (2017).
24. Schonwetter RS., et al. “Predictors of six-month survival among patients with dementia: an evaluation of hospice Medicare guidelines”. American Journal of Hospice and Palliative Medicine®2 (2003): 105-113.
25. Aminoff BZ and Adunsky A. “Their last 6 months: suffering and survival of end-stage dementia patients”. Age and Ageing6 (2006): 597-601.

Citation

Citation: Fatemeh Hajibabaee and Hadis Ashrafizadeh. “Alzheimer's Patients Need End-of-Life Care: A Necessity Neglected”. Acta Scientific Women's Health 3.6 (2021): 130-134.

Copyright

Copyright: © 2021 Fatemeh Hajibabaee and Hadis Ashrafizadeh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.